{"id":"https://openalex.org/W4361957232","doi":"https://doi.org/10.1158/1535-7163.c.6531555.v1","title":"Data from Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program","display_name":"Data from Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361957232","doi":"https://doi.org/10.1158/1535-7163.c.6531555.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6531555.v1","doi":"https://doi.org/10.1158/1535-7163.c.6531555.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6531555.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6531555.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109173471","display_name":"Peter J. Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066877678","display_name":"Christopher L. Morton","orcid":"https://orcid.org/0000-0002-4027-7050","observed_orcids":["https://orcid.org/0000-0002-4027-7050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher L. Morton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032743242","display_name":"Richard Greg Gorlick","orcid":"https://orcid.org/0000-0001-8995-2929","observed_orcids":["https://orcid.org/0000-0001-8995-2929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Gorlick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard B. Lock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170888","display_name":"Hern\u00e1n Carol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hernan Carol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058354009","display_name":"C. Patrick Reynolds","orcid":"https://orcid.org/0000-0002-2827-8536","observed_orcids":["https://orcid.org/0000-0002-2827-8536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Patrick Reynolds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035381341","display_name":"Min H. Kang","orcid":"https://orcid.org/0000-0003-3603-7035","observed_orcids":["https://orcid.org/0000-0003-3603-7035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min H. Kang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005797590","display_name":"John M. Maris","orcid":"https://orcid.org/0000-0002-8088-7929","observed_orcids":["https://orcid.org/0000-0002-8088-7929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Maris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025528414","display_name":"Stephen Thomas Keir","orcid":"https://orcid.org/0000-0001-8630-3587","observed_orcids":["https://orcid.org/0000-0001-8630-3587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen T. Keir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009981843","display_name":"Edward Anders Kolb","orcid":"https://orcid.org/0000-0003-2854-9014","observed_orcids":["https://orcid.org/0000-0003-2854-9014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Anders Kolb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060308592","display_name":"Jianrong Wu","orcid":"https://orcid.org/0000-0002-3519-5894","observed_orcids":["https://orcid.org/0000-0002-3519-5894","https://orcid.org/0000-0003-2395-4619","https://orcid.org/0000-0002-5598-0478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianrong Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070962895","display_name":"Amy W. Wozniak","orcid":"https://orcid.org/0000-0002-0670-3677","observed_orcids":["https://orcid.org/0000-0002-0670-3677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy W. Wozniak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048193615","display_name":"Catherine A. Billups","orcid":"https://orcid.org/0000-0003-2819-4946","observed_orcids":["https://orcid.org/0000-0003-2819-4946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine A. Billups","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033078993","display_name":"Larry Rubinstein","orcid":"https://orcid.org/0000-0002-9720-9737","observed_orcids":["https://orcid.org/0000-0002-9720-9737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larry Rubinstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046943976","display_name":"Malcolm Anders Smith","orcid":"https://orcid.org/0000-0001-9880-9876","observed_orcids":["https://orcid.org/0000-0001-9880-9876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malcolm A. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.02290000021457672,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.628000020980835},{"id":"https://openalex.org/keywords/pediatric-malignancies","display_name":"pediatric malignancies","score":0.6449999809265137},{"id":"https://openalex.org/keywords/childhood-tumors","display_name":"childhood tumors","score":0.5609999895095825},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.7080000042915344},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9700000286102295},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.996999979019165},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7020000219345093},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.5450000166893005},{"id":"https://openalex.org/keywords/leukemia-model","display_name":"leukemia model","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7332584857940674},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6173179745674133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5827069282531738},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.549791693687439},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5427863597869873},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4940831959247589},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49348223209381104},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4795358180999756},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4552052319049835},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3674704134464264},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2448229193687439},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22380635142326355},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21262165904045105},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17402240633964539},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6531555.v1","doi":"https://doi.org/10.1158/1535-7163.c.6531555.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6531555.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6531555.v1","doi":"https://doi.org/10.1158/1535-7163.c.6531555.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6531555.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6200000047683716,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164458048","https://openalex.org/W7096860826","https://openalex.org/W2003537331","https://openalex.org/W1994008293","https://openalex.org/W2116355318","https://openalex.org/W3103837902","https://openalex.org/W2434985937","https://openalex.org/W2004635293","https://openalex.org/W3094235523","https://openalex.org/W3083358540"],"abstract_inverted_index":{"Abstract":[0],"Rapamycin":[1,40],"demonstrated":[2,135,243],"broad-spectrum":[3],"tumor":[4],"growth":[5],"inhibition":[6],"activity":[7,129],"against":[8,45],"the":[9,18,35,64,79,99,103,156,175,238],"in":[10,17,34,43,51,112,123,143],"vivo":[11,133],"panels":[12],"of":[13,37,66,151,163,193,214,237],"childhood":[14,38],"tumors":[15],"used":[16,32,105,179],"Pediatric":[19],"Preclinical":[20],"Testing":[21],"Program":[22],"(PPTP).":[23],"Here":[24],"we":[25],"have":[26],"evaluated":[27,74,242],"rapamycin":[28,68,108,142,157,164,194,215],"combined":[29],"with":[30,53,69,109,145,165],"agents":[31,104,111,178],"frequently":[33],"treatment":[36],"malignancies.":[39],"was":[41,73,130,139,207],"tested":[42],"vitro":[44,113],"23":[46],"cell":[47],"lines":[48],"alone":[49,180],"or":[50,57,117,168,219],"combination":[52,100,144,192],"melphalan,":[54],"cisplatin,":[55],"vincristine,":[56],"dexamethasone":[58,122],"(leukemic":[59],"models":[60,125,241],"only).":[61],"In":[62,132],"vivo,":[63],"impact":[65],"combining":[67],"a":[70,85],"cytotoxic":[71,110],"agent":[72],"using":[75],"two":[76],"measures:":[77],"1)":[78],"therapeutic":[80,137,205,244],"enhancement":[81,138,206,245],"measure,":[82],"and":[83,96,147,158,195,204,234],"2)":[84],"linear":[86],"regression":[87],"model":[88],"for":[89,94,98,121,126,141,149,155,187,210,246],"time-to-event":[90],"to":[91,102,216],"formally":[92],"evaluate":[93],"sub-":[95],"supraadditivity":[97],"compared":[101],"alone.":[106],"Combining":[107],"gave":[114],"predominantly":[115],"subadditive":[116],"additive":[118],"effects,":[119],"except":[120],"leukemia":[124],"which":[127],"supra-additive":[128],"observed.":[131],"testing":[134],"that":[136],"common":[140],"cyclophosphamide":[146,167,218],"occurred":[148],"4":[150],"11":[152],"evaluable":[153,189],"xenografts":[154],"vincristine":[159,169,220],"combination.":[160,212],"The":[161,191],"combinations":[162,229],"either":[166,217],"were":[170],"significantly":[171],"more":[172],"effective":[173],"than":[174],"respective":[176,223],"standard":[177],"at":[181,221],"their":[182,222],"maximum":[183],"tolerated":[184,233],"doses":[185],"(MTD)":[186],"most":[188],"xenografts.":[190],"cisplatin":[196,201],"produced":[197],"excessive":[198],"toxicity":[199],"requiring":[200],"dose":[202],"reductions,":[203],"not":[208],"observed":[209],"this":[211],"Addition":[213],"MTDs":[224],"appears":[225],"promising,":[226],"as":[227,235],"these":[228,247],"are":[230],"relatively":[231],"well":[232],"many":[236],"pediatric":[239],"preclinical":[240],"combinations.":[248],"Mol":[249],"Cancer":[250],"Ther;":[251],"9(1);":[252],"101\u201312":[253]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}